Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1992 Mar;89(3):899–908. doi: 10.1172/JCI115670

High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells.

G Milazzo 1, C C Yip 1, B A Maddux 1, R Vigneri 1, I D Goldfine 1
PMCID: PMC442936  PMID: 1311720

Abstract

We studied the nature of insulin receptor binding in MCF-7 breast cancer cells. In both intact cells and solubilized receptor preparations, high-affinity insulin binding was seen. However, unlabeled insulin-like growth factor-I (IGF-I) was five-fold more potent in inhibiting 125I-insulin binding than insulin itself. With monoclonal antibodies to the insulin receptor, 30% of 125I-insulin binding was inhibited. In contrast when alpha-IR3, a monoclonal antibody that recognizes typical IGF-I receptor, was employed over 60% of 125I-insulin binding was inhibited. The B29-MAB-125I-insulin photoprobe was then cross-linked to MCF-7 membranes. Cross-linking was inhibited by both unlabeled insulin and IGF-I. Further, the B29-MAB-125I-insulin photoprobe cross-linked to MCF-7 membranes was strongly immunoprecipitated by alpha-IR3. Employing sequential affinity chromatography with insulin-Affi-gel followed by insulin receptor monoclonal antibody agarose, atypical insulin binding activity was separated from insulin receptor binding activity. This atypical receptor had intrinsic tyrosine kinase activity. Both insulin and IGF-I stimulated the phosphorylation of the receptor's beta subunit. In MCF-7 cells both IGF-I and insulin stimulated [3H]thymidine incorporation; alpha-IR3 blocked all of the IGF-I effect but only 50-60% of the insulin effect. This study demonstrates in MCF-7 cells that, in addition to typical insulin and IGF-I receptors, there is another receptor that binds both insulin and IGF-I with high affinity.

Full text

PDF
899

Images in this article

901Image
on p.901
901Image
on p.901
903Image
on p.903
904Image
on p.904
904Image
on p.904
904Image
on p.904
904Image
on p.904
905Image
on p.905

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexandrides T. K., Smith R. J. A novel fetal insulin-like growth factor (IGF) I receptor. Mechanism for increased IGF I- and insulin-stimulated tyrosine kinase activity in fetal muscle. J Biol Chem. 1989 Aug 5;264(22):12922–12930. [PubMed] [Google Scholar]
  2. Cullen K. J., Yee D., Sly W. S., Perdue J., Hampton B., Lippman M. E., Rosen N. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res. 1990 Jan 1;50(1):48–53. [PubMed] [Google Scholar]
  3. Ebina Y., Ellis L., Jarnagin K., Edery M., Graf L., Clauser E., Ou J. H., Masiarz F., Kan Y. W., Goldfine I. D. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell. 1985 Apr;40(4):747–758. doi: 10.1016/0092-8674(85)90334-4. [DOI] [PubMed] [Google Scholar]
  4. Forsayeth J. R., Montemurro A., Maddux B. A., DePirro R., Goldfine I. D. Effect of monoclonal antibodies on human insulin receptor autophosphorylation, negative cooperativity, and down-regulation. J Biol Chem. 1987 Mar 25;262(9):4134–4140. [PubMed] [Google Scholar]
  5. Forsayeth J., Maddux B., Goldfine I. D. Biosynthesis and processing of the human insulin receptor. Diabetes. 1986 Jul;35(7):837–846. doi: 10.2337/diab.35.7.837. [DOI] [PubMed] [Google Scholar]
  6. Froesch E. R., Schmid C., Schwander J., Zapf J. Actions of insulin-like growth factors. Annu Rev Physiol. 1985;47:443–467. doi: 10.1146/annurev.ph.47.030185.002303. [DOI] [PubMed] [Google Scholar]
  7. Furlanetto R. W., DiCarlo J. N. Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture. Cancer Res. 1984 May;44(5):2122–2128. [PubMed] [Google Scholar]
  8. Giorgino F., Belfiore A., Milazzo G., Costantino A., Maddux B., Whittaker J., Goldfine I. D., Vigneri R. Overexpression of insulin receptors in fibroblast and ovary cells induces a ligand-mediated transformed phenotype. Mol Endocrinol. 1991 Mar;5(3):452–459. doi: 10.1210/mend-5-3-452. [DOI] [PubMed] [Google Scholar]
  9. Goldfine I. D. The insulin receptor: molecular biology and transmembrane signaling. Endocr Rev. 1987 Aug;8(3):235–255. doi: 10.1210/edrv-8-3-235. [DOI] [PubMed] [Google Scholar]
  10. Hartmann K. K., Papa V., Brown E. J., Doerries U., Rosenthal S. M., Goldfine I. D. A rapid and simple one step method for isolation of poly(A)+ RNA from cells in monolayer. Endocrinology. 1990 Oct;127(4):2038–2040. doi: 10.1210/endo-127-4-2038. [DOI] [PubMed] [Google Scholar]
  11. Hawley D. M., Maddux B. A., Patel R. G., Wong K. Y., Mamula P. W., Firestone G. L., Brunetti A., Verspohl E., Goldfine I. D. Insulin receptor monoclonal antibodies that mimic insulin action without activating tyrosine kinase. J Biol Chem. 1989 Feb 15;264(5):2438–2444. [PubMed] [Google Scholar]
  12. Jacobs S., Kull F. C., Jr, Earp H. S., Svoboda M. E., Van Wyk J. J., Cuatrecasas P. Somatomedin-C stimulates the phosphorylation of the beta-subunit of its own receptor. J Biol Chem. 1983 Aug 25;258(16):9581–9584. [PubMed] [Google Scholar]
  13. Kasuga M., Karlsson F. A., Kahn C. R. Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science. 1982 Jan 8;215(4529):185–187. doi: 10.1126/science.7031900. [DOI] [PubMed] [Google Scholar]
  14. Kasuga M., Sasaki N., Kahn C. R., Nissley S. P., Rechler M. M. Antireceptor antibodies as probes of insulinlike growth factor receptor structure. J Clin Invest. 1983 Oct;72(4):1459–1469. doi: 10.1172/JCI111102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kasuga M., Van Obberghen E., Nissley S. P., Rechler M. M. Demonstration of two subtypes of insulin-like growth factor receptors by affinity cross-linking. J Biol Chem. 1981 Jun 10;256(11):5305–5308. [PubMed] [Google Scholar]
  16. Kull F. C., Jr, Jacobs S., Su Y. F., Svoboda M. E., Van Wyk J. J., Cuatrecasas P. Monoclonal antibodies to receptors for insulin and somatomedin-C. J Biol Chem. 1983 May 25;258(10):6561–6566. [PubMed] [Google Scholar]
  17. Lippman M. E., Dickson R. B., Gelmann E. P., Rosen N., Knabbe C., Bates S., Bronzert D., Huff K., Kasid A. Growth regulation of human breast carcinoma occurs through regulated growth factor secretion. J Cell Biochem. 1987 Sep;35(1):1–16. doi: 10.1002/jcb.240350102. [DOI] [PubMed] [Google Scholar]
  18. McFarland K. C., Ramachandran J., Grunfeld C. Peptide-based radioimmunoassay for insulin receptor. Detection of insulin-stimulated downregulation in IM-9 lymphocytes. Diabetes. 1989 Aug;38(8):987–990. doi: 10.2337/diab.38.8.987. [DOI] [PubMed] [Google Scholar]
  19. Moxham C. P., Duronio V., Jacobs S. Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers. J Biol Chem. 1989 Aug 5;264(22):13238–13244. [PubMed] [Google Scholar]
  20. Osborne C. K., Bolan G., Monaco M. E., Lippman M. E. Hormone responsive human breast cancer in long-term tissue culture: effect of insulin. Proc Natl Acad Sci U S A. 1976 Dec;73(12):4536–4540. doi: 10.1073/pnas.73.12.4536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Osborne C. K., Monaco M. E., Lippman M. E., Kahn C. R. Correlation among insulin binding, degradation, and biological activity in human breast cancer cells in long-term tissue culture. Cancer Res. 1978 Jan;38(1):94–102. [PubMed] [Google Scholar]
  22. Papa V., Pezzino V., Costantino A., Belfiore A., Giuffrida D., Frittitta L., Vannelli G. B., Brand R., Goldfine I. D., Vigneri R. Elevated insulin receptor content in human breast cancer. J Clin Invest. 1990 Nov;86(5):1503–1510. doi: 10.1172/JCI114868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pezzino V., Milazzo G., Frittitta L., Vigneri R., Ezaki O., Kasahara M., LeBon T. R., Goldfine I. D., Fujita-Yamaguchi Y. Radioimmunoassay for human insulin-like growth factor-I receptor: applicability to breast carcinoma specimens and cell lines. Metabolism. 1991 Aug;40(8):861–865. doi: 10.1016/0026-0495(91)90016-p. [DOI] [PubMed] [Google Scholar]
  24. Pezzino V., Papa V., Trischitta V., Brunetti A., Goodman P. A., Treutelaar M. K., Williams J. A., Maddux B. A., Vigneri R., Goldfine I. D. Human insulin receptor radioimmunoassay: applicability to insulin-resistant states. Am J Physiol. 1989 Sep;257(3 Pt 1):E451–E457. doi: 10.1152/ajpendo.1989.257.3.E451. [DOI] [PubMed] [Google Scholar]
  25. Rechler M. M., Nissley S. P. The nature and regulation of the receptors for insulin-like growth factors. Annu Rev Physiol. 1985;47:425–442. doi: 10.1146/annurev.ph.47.030185.002233. [DOI] [PubMed] [Google Scholar]
  26. Rechler M. M., Zapf J., Nissley S. P., Froesch E. R., Moses A. C., Podskalny J. M., Schilling E. E., Humbel R. E. Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins. Endocrinology. 1980 Nov;107(5):1451–1459. doi: 10.1210/endo-107-5-1451. [DOI] [PubMed] [Google Scholar]
  27. Rosenthal S. M., Brunetti A., Brown E. J., Mamula P. W., Goldfine I. D. Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation. Potential autocrine role of IGF-II. J Clin Invest. 1991 Apr;87(4):1212–1219. doi: 10.1172/JCI115121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Roth R. A., Cassell D. J., Maddux B. A., Goldfine I. D. Regulation of insulin receptor kinase activity by insulin mimickers and an insulin antagonist. Biochem Biophys Res Commun. 1983 Aug 30;115(1):245–252. doi: 10.1016/0006-291x(83)90996-8. [DOI] [PubMed] [Google Scholar]
  29. Soos M. A., Siddle K. Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors. Biochem J. 1989 Oct 15;263(2):553–563. doi: 10.1042/bj2630553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Soos M. A., Whittaker J., Lammers R., Ullrich A., Siddle K. Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells. Biochem J. 1990 Sep 1;270(2):383–390. doi: 10.1042/bj2700383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Stampfer M. R., Bartley J. C. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. Proc Natl Acad Sci U S A. 1985 Apr;82(8):2394–2398. doi: 10.1073/pnas.82.8.2394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Stewart A. J., Johnson M. D., May F. E., Westley B. R. Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem. 1990 Dec 5;265(34):21172–21178. [PubMed] [Google Scholar]
  33. Straus D. S. Growth-stimulatory actions of insulin in vitro and in vivo. Endocr Rev. 1984 Spring;5(2):356–369. doi: 10.1210/edrv-5-2-356. [DOI] [PubMed] [Google Scholar]
  34. Tollefsen S. E., Thompson K., Petersen D. J. Separation of the high affinity insulin-like growth factor I receptor from low affinity binding sites by affinity chromatography. J Biol Chem. 1987 Dec 5;262(34):16461–16469. [PubMed] [Google Scholar]
  35. Treadway J. L., Morrison B. D., Goldfine I. D., Pessin J. E. Assembly of insulin/insulin-like growth factor-1 hybrid receptors in vitro. J Biol Chem. 1989 Dec 25;264(36):21450–21453. [PubMed] [Google Scholar]
  36. Ullrich A., Bell J. R., Chen E. Y., Herrera R., Petruzzelli L. M., Dull T. J., Gray A., Coussens L., Liao Y. C., Tsubokawa M. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. 1985 Feb 28-Mar 6Nature. 313(6005):756–761. doi: 10.1038/313756a0. [DOI] [PubMed] [Google Scholar]
  37. Ullrich A., Gray A., Tam A. W., Yang-Feng T., Tsubokawa M., Collins C., Henzel W., Le Bon T., Kathuria S., Chen E. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 1986 Oct;5(10):2503–2512. doi: 10.1002/j.1460-2075.1986.tb04528.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Waldbillig R. J., Chader G. J. Anomalous insulin-binding activity in the bovine neural retina: a possible mechanism for regulation of receptor binding specificity. Biochem Biophys Res Commun. 1988 Mar 30;151(3):1105–1112. doi: 10.1016/s0006-291x(88)80480-7. [DOI] [PubMed] [Google Scholar]
  39. Yip C. C., Grunfeld C., Goldfine I. D. Identification and characterization of the ligand-binding domain of insulin receptor by use of an anti-peptide antiserum against amino acid sequence 241-251 of the alpha subunit. Biochemistry. 1991 Jan 22;30(3):695–701. doi: 10.1021/bi00217a016. [DOI] [PubMed] [Google Scholar]
  40. Yip C. C., Hsu H., Patel R. G., Hawley D. M., Maddux B. A., Goldfine I. D. Localization of the insulin-binding site to the cysteine-rich region of the insulin receptor alpha-subunit. Biochem Biophys Res Commun. 1988 Nov 30;157(1):321–329. doi: 10.1016/s0006-291x(88)80050-0. [DOI] [PubMed] [Google Scholar]
  41. Yip C. C., Yeung C. W., Moule M. L. Photoaffinity labeling of insulin receptor proteins of liver plasma membrane preparations. Biochemistry. 1980 Jan 8;19(1):70–76. doi: 10.1021/bi00542a011. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES